Pamela J. Boimel, MD, PHD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
LG Health Physicians Radiation Oncology
Headshot of Pamela J. Boimel, MD, PHD
Penn Medicine Provider

About me

  • Medical Director, Radiation Oncology, Penn Medicine Lancaster General Health
  • Director, Proton Therapy, Penn Medicine Lancaster General Health
  • Director, Radiation Research, Penn Medicine Lancaster General Health
  • Adjunct Assistant Professor of Radiation Oncology

My education and training

  • Medical School: Albert Einstein College of Medicine
  • Residency: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

113 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
July 2026
i think she's a great doctor and is interested in my health
Anonymous
July 2026
answered all questions
Anonymous
July 2026
i feel very comfortable with her.
Anonymous
June 2026
dr. biomel has a good amount of experience and i can have confidence in that.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Boimel is a Penn Medicine Lancaster General Health physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Men K, Boimel P, Janopaul-Naylor J, Cheng C, Zhong H, Huang M, Geng H, Fan Y, Plastaras JP, Ben-Josef E, Xiao Y A study of positioning orientation effect on segmentation accuracy using conventional neural networks for rectal cancer , J Appl Clin Med Phys, 20(1): 2019,110-117


Boimel PJ, Binder KR, Hong TS, Feng M, Ben-Josef E Cholangiocarcinoma and Gallbladder Cases: An Expert Panel Case-Based Discussion , Semin Radiat Oncol, 28(4): 2018,351-361


Men K, Boimel P, Janopaul-Naylor J, Zhong H, Huang M, Geng H, Cheng C, Fan Y, Plastaras JP, Ben-Josef E, Xiao Y Cascaded atrous convolution and spatial pyramaid pooling for more accurate tumor target segmentation for rectal cancer radiotherapy , Phys Med Biol, 63(18): 2018


Boimel PJ, Scholey JE, Lin L, Ben-Josef E Treating Pancreatic and Stomach malignancies with Proton beam radiation. Target Volume Delineation and Treatment Planning for Particle Therapy. , Springer International Publishing, Switzerland: 2018


Scholey JE, Boimel PJ, Kirk M, Lin L Gynecologic Malignancies. Target Volume Delineation and Treatment Planning for Particle Therapy , Springer International Publishing, Switzerland: 2018


Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP Proton reirradiation for locally recurrent pancreatic adenocarcinoma , J. Gastrointestinal Oncology: 2017


Dutta SW, Trifiletti DM, Grover S, Boimel P, Showalter TN Management of elderly patients with early-stage medically inoperable endometrial cancer: Systematic review and National Cancer Database analysis , Brachytherapy, 16(3): 2017,526-533


Li H, Zhong H, Boimel PJ, Ben-Josef E, Xiao Y, Fan Y Deep convolutional neural networks for imaging based survival analysis of rectal cancer patients , Selected for ePoster Discussion at the ASTRO Annual Meeting: 2017


Schonewolf CA, Boimel PJ, Brensinger CM, Liu Q, Ko EM, Lin L Patterns of Care and Outcomes of Adjuvant Radiotherapy for Stage II Endometrioid Uterine Cancer: A Surveillance, Epidemiology, and End Results (SEER) and Medicare Linked Analysis , Selected for Poster Presentation at the ASTRO Annual Meeting: 2017


Zhong H, Boimel PJ, Fan Y, Wang J, Geng H, Huang M, Cheng C, Rosen, M, Ben-Josef E, Xiao Y Predicting overall survival of local advanced rectal cancer patients treated with neoadjuvant chemo-radiotherapy by radiomic features extracted from planning CTs , Selected for Poster Presentation at the ASTRO Annual Meeting: 2017